ReviewPharmaceuticals (Basel, Switzerland)2020
Role of 2-[
Review in Pharmaceuticals (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 30 citations in OpenAlex.
- Emotional stress during the COVID-19 lockdown: how negative X/Twitter posts correlated with changes in the brain's fear network.Frontiers in nuclear medicine · 2025Article
- The effect of COVID-19 on nuclear medicine and radiopharmacy activities: A global survey.Scientific reports · 2023Article
- Clinical value ofFrontiers in oncology · 2023Review
- COVID-19 vaccine related hypermetabolic lymph nodes on PET/CT: Implications of inflammatory findings in cancer imaging.Oncology research · 2023Article
- The value of FDG-PET/CT imaging in the assessment, monitoring, and management of COVID-19.European physical journal plus · 2023Review
- [Diagnostics (Basel, Switzerland) · 2022Article
- A case-control evaluation of pulmonary and extrapulmonary findings of incidental asymptomatic COVID-19 infection on FDG PET-CT.The British journal of radiology · 2022Article
- Incidental Findings Suggestive of COVID-19 Pneumonia in Oncologic Patients UndergoingJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Article
- Nuclear Medicine During the COVID-19 Pandemic: The Show Must Go On.Frontiers in medicine · 2022Article
- Nuclear Medicine Departments in the Era of COVID-19.Seminars in nuclear medicine · 2022Review
- Oncology and cardiology positron emission tomography/computed tomography faced with COVID-19: A review of available literature data.Frontiers in medicine · 2022Review
- Article
- Impact of COVID-19 pandemic on 2-[Heliyon · 2022Article
- FDG PET/CT imaging features and clinical utility in COVID-19.Clinical imaging · 2021Article
- Positron emission tomography in the COVID-19 pandemic era.European journal of nuclear medicine and molecular imaging · 2021Review
- Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study.European journal of nuclear medicine and molecular imaging · 2021Article
- Prevalence and Significance of Hypermetabolic Lymph Nodes Detected by 2-[Pharmaceuticals (Basel, Switzerland) · 2021Review
- Prevalence of interstitial pneumonia suggestive of COVID-19 atEuropean journal of nuclear medicine and molecular imaging · 2021Observational
- Global research trends in COVID-19 with MRI and PET/CT: a scoping review with bibliometric and network analyses.Clinical and translational imaging · 2021Article
- COVID-19 and Aspiration Pneumonia: Similar Pulmonary Findings with Different Diagnoses-a Pitfall in [18F]FDG PET/CT.SN comprehensive clinical medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Some recent studies evaluated the role of fluorine-18 fluorodeoxyglucose (2-[
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.